Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?
about
Media, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medicationsPotential spillover educational effects of cancer-related direct-to-consumer advertising on cancer patients' increased information seeking behaviors: results from a cohort study.A literature review and meta-analysis of drug company-funded mental health websites.Results from an online survey of patient and caregiver perspectives on unmet needs in the treatment of bipolar disorder.Clinically significant psychotropic drug-drug interactions in the primary care setting.Consumers' various and surprising responses to direct-to-consumer advertisements in magazine print.General public knowledge, perceptions and practice towards pharmaceutical drug advertisements in the Western region of KSA.Prescription drug advertising, disease knowledge, and older adults' optimistic bias about the future risk of Alzheimer's disease.Then and Now: Examining How Consumer Communication and Attitudes of Direct-to-Consumer Pharmaceutical Advertising Have Changed in the Last Decade.Direct-to-consumer (DTC) antidepressant advertising and consumer misperceptions about the chemical imbalance theory of depression: the moderating role of skepticism.Thinking outside the medicine cabinet: a comparative content analysis of direct-to-consumer advertisements for prescription drug treatments.Erectile dysfunction and the internet: drug company manipulation of public and professional opinion.Reasons for and predictors of patients' online health information seeking following a medical appointment.The prepared patient: information seeking of online support group members before their medical appointments.
P2860
Q27013553-6ED334B1-4ED5-4F49-8CBE-DB1ACD6ED8F0Q33639174-F649AFE9-F36A-4EDF-BA7E-EA641E2FA8F2Q34344001-36DA47EC-20CA-4AD5-9721-5538226FEDDCQ35054265-249587E4-3C13-4E35-9161-4FD2EAFA0BCFQ35104220-80C6DEBE-FB1F-4DF1-98E1-7163D336E7E4Q36567521-C9A6B35E-4BC6-4D45-A063-BFF6FA1340B8Q37631474-312EDAC9-2D4D-4945-904B-37714DCA5FF4Q38964947-882F4C1C-AF92-4E6E-9CCF-5C436A0B0960Q39315585-2528E013-8766-4A75-9AF3-1BE6F6709AA8Q43526310-A5D926FF-1403-4BA6-8567-1A457393C580Q44337908-B92819C4-85F3-4F8C-9B9B-BA0B0E2058E6Q46262890-F041F957-02BD-46E3-AD8D-36DE9D440F83Q46467298-C57DBD2A-D2AB-4118-93C4-E55E145B2B42Q46938682-722FB594-2052-485C-8CDB-D78F908A1CF6
P2860
Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Do antidepressant advertisemen ...... pression and their physicians?
@ast
Do antidepressant advertisemen ...... pression and their physicians?
@en
type
label
Do antidepressant advertisemen ...... pression and their physicians?
@ast
Do antidepressant advertisemen ...... pression and their physicians?
@en
prefLabel
Do antidepressant advertisemen ...... pression and their physicians?
@ast
Do antidepressant advertisemen ...... pression and their physicians?
@en
P2860
P1476
Do antidepressant advertisemen ...... pression and their physicians?
@en
P2093
Laramie D Taylor
Robert A Bell
P2860
P304
P356
10.1016/J.PEC.2010.01.014
P577
2010-02-21T00:00:00Z